{"id":624330,"title":"Notice of Amendment: Revision of Brimonidine on the Prescription Drug List (PDL) - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-02-27","captureTimestamp":"2026-02-27T00:30:06.473000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/amendment-revision-brimonidine.html","snippet":"Notice of Amendment: Revision of Brimonidine on the Prescription Drug List (PDL) May 16, 2022 Our file number: 22-105587-718 The purpose of this Notice of Amendment is to notify that Health Canada has revised the listing of \"brimonidine or its salts\" on the Prescription Drug List…","rawSnapshotUrl":"/api/snapshots/raw/624330","browseUrl":"https://replay.healtharchive.ca/job-6/20260227003006/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/amendment-revision-brimonidine.html#ha_snapshot=624330","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}